Clinical trial Recruiting at 1 site Interventional Ages 4 to 9

Detecting leftover decay on Class II cavity walls in primary teeth after atraumatic restorative treatment

Official title: Detection of Residual Caries on Class II Cavity Walls in Primary Teeth Following Atraumatic Restorative Treatment (ART): A Comparative Evaluation of Fluorescence-Aided Caries Excavation (FACE), Caries Detection Dye, and Clinical Assessment

Run by Çanakkale Onsekiz Mart University · NCT07250022 · Data updated 2026-11-12

This tests whether a fluorescence device (FACE), a staining dye, or visual-tactile checks best find leftover decay on cavity walls in children aged 4–9 after atraumatic restorative treatment.

Quick facts

Study typeInterventional
Ages4 Years to 9 Years
SexAll
Enrollment212 (estimated)
SponsorÇanakkale Onsekiz Mart University
Academic / other
Locations1 site (Çanakkale, Kepez)
StatusRecruiting
StartedDecember 20, 2025
Main results expectedFebruary 1, 2026
Study endsFebruary 15, 2026
Registry record updatedJanuary 21, 2026
Trial IDNCT07250022 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy, cooperative children aged 4–9 with asymptomatic multi-surface carious cavities in primary teeth whose parent/guardian provides written consent and who give assent are ideal candidates.

Probably not a fit

Children with acute dental infection, systemic health conditions, inability to cooperate, or those without suitable multi-surface carious lesions are unlikely to be eligible or to benefit from the methods tested.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

After ART is performed on asymptomatic multi-surface carious lesions in primary teeth of cooperative children aged 4–9, clinicians will use three methods—FACE, caries detection dye, and visual-tactile examination—to detect residual caries on Class II cavity walls. The study compares diagnostic agreement and effectiveness of these approaches to determine which method most reliably identifies remaining infected dentin while minimizing removal of healthy tissue. Outcomes include concordance between methods and the frequency of detected residual caries, with all procedures performed at a single university dental clinic. Findings are intended to inform clinical choices for confirming complete caries removal during ART.

Why it matters

Potential benefit: If successful, this could help dentists more accurately detect and remove leftover decay during ART, reducing repeat treatments and preserving healthy tooth structure in children.

How similar studies have gone: Previous work shows FACE has promise for improving visual detection of caries while caries detection dyes often over-stain demineralized but noninfected dentin, so evidence is mixed but FACE is encouraging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 4-9 years at enrollment
* Healthy children who can cooperate with dental examination
* Multi-surface carious cavities that are asymptomatic (no acute symptoms)
* Written informed consent from parent/guardian and assent from the child

Exclusion Criteria:

* Acute dental infection present
* Any systemic disease/condition
* Lack of cooperation during the procedure
* Refusal to participate / informed consent not obtained from parent/guardian and/or assent not obtained from the child

Where it's running

  • Canakkale Onsekiz Mart University
    Çanakkale, Kepez, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Burak Çarıkçıoğlu, Associate Professor — Çanakkale Onsekiz Mart University
  • Study coordinator: Burak Çarıkçıoğlu, Associate Professor
  • Email: carikcioglub@gmail.com
  • Phone: 00905054956091

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.